193 related articles for article (PubMed ID: 30460625)
21. Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist.
Yasukawa T; Hoffmann S; Eichler W; Friedrichs U; Wang YS; Wiedemann P
Curr Eye Res; 2004 May; 28(5):359-66. PubMed ID: 15287373
[TBL] [Abstract][Full Text] [Related]
22. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
Ocampo-García BE; Santos-Cuevas CL; De León-Rodríguez LM; García-Becerra R; Ordaz-Rosado D; Luna-Guitiérrez MA; Jiménez-Mancilla NP; Romero-Piña ME; Ferro-Flores G
Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768
[TBL] [Abstract][Full Text] [Related]
23. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
Dearling JL; Barnes JW; Panigrahy D; Zimmerman RE; Fahey F; Treves ST; Morrison MS; Kieran MW; Packard AB
Nucl Med Biol; 2013 Aug; 40(6):788-94. PubMed ID: 23701702
[TBL] [Abstract][Full Text] [Related]
24. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
25. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236
[TBL] [Abstract][Full Text] [Related]
26. Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization.
Meyer JH; Larsen PP; Strack C; Harmening WM; Krohne TU; Holz FG; Schmitz-Valckenberg S
Exp Eye Res; 2019 Jul; 184():162-171. PubMed ID: 31002822
[TBL] [Abstract][Full Text] [Related]
27. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
28. Comparison of biological properties of
Zhao ZQ; Yang Y; Fang W; Liu S
Nucl Med Biol; 2016 Nov; 43(11):661-669. PubMed ID: 27556955
[TBL] [Abstract][Full Text] [Related]
29. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.
Lai K; Xu L; Jin C; Wu K; Tian Z; Huang C; Zhong X; Ye H
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5702-12. PubMed ID: 21666238
[TBL] [Abstract][Full Text] [Related]
30. Integrin Imaging with
Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
[TBL] [Abstract][Full Text] [Related]
31. Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
Ji S; Zhou Y; Voorbach MJ; Shao G; Zhang Y; Fox GB; Albert DH; Luo Y; Liu S; Mudd SR
J Pharmacol Exp Ther; 2013 Aug; 346(2):251-8. PubMed ID: 23750021
[TBL] [Abstract][Full Text] [Related]
32. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
33. An improved kit formulation for one-pot synthesis of [
Chakraborty S; Das S; Chakravarty R; Sarma HD; Vatsa R; Shukla J; Mittal BR; Dash A
J Labelled Comp Radiopharm; 2019 Oct; 62(12):823-834. PubMed ID: 31315149
[TBL] [Abstract][Full Text] [Related]
34. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
[TBL] [Abstract][Full Text] [Related]
35. In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD.
Dimastromatteo J; Riou LM; Ahmadi M; Pons G; Pellegrini E; Broisat A; Sancey L; Gavrilina T; Boturyn D; Dumy P; Fagret D; Ghezzi C
J Nucl Cardiol; 2010 Jun; 17(3):435-43. PubMed ID: 20087797
[TBL] [Abstract][Full Text] [Related]
36. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD 2 in non-human primates.
Jia B; Liu Z; Zhu Z; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Mol Imaging Biol; 2011 Aug; 13(4):730-6. PubMed ID: 20694579
[TBL] [Abstract][Full Text] [Related]
37. Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization.
Salehi-Had H; Roh MI; Giani A; Hisatomi T; Nakao S; Kim IK; Gragoudas ES; Vavvas D; Guccione S; Miller JW
PLoS One; 2011 Apr; 6(4):e18864. PubMed ID: 21559527
[TBL] [Abstract][Full Text] [Related]
38. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction.
Kalinowski L; Dobrucki LW; Meoli DF; Dione DP; Sadeghi MM; Madri JA; Sinusas AJ
J Appl Physiol (1985); 2008 May; 104(5):1504-12. PubMed ID: 18356482
[TBL] [Abstract][Full Text] [Related]
39. Anti-angiogenic effects of non-peptide integrin alphavbeta3 specific antagonist on laser-induced choroidal neovascularization in mice.
Honda S; Nagai T; Negi A
Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):515-22. PubMed ID: 19048271
[TBL] [Abstract][Full Text] [Related]
40. SPECT/CT of lung nodules using 111In-DOTA-c(RGDfK) in a mouse lung carcinogenesis model.
Hayakawa T; Mutoh M; Imai T; Tsuta K; Yanaka A; Fujii H; Yoshimoto M
Ann Nucl Med; 2013 Aug; 27(7):640-7. PubMed ID: 23609239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
